Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: Effect on drug-plasma AUC and peripheral blood drug-DNA adduct levels

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

A. Hilary Calvert, David R. Newell, Lindsey Gumbrell et al. · Journal of Clinical Oncology · 1989 · 1.9K citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

Richard J. Knox, Frank Friedlos, David Lydall et al. · PubMed · 1986 · 499 citations

Medicine, Oncology, Pharmacology +15

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II

A. Hilary Calvert, S.J. Harland, David R. Newell et al. · Cancer Chemotherapy and Pharmacology · 1982 · 486 citations

Medicine, Medicinal Chemistry, Pharmacology +5

Oxford textbook of oncology

Michael Peckham, Herbert M. Pinedo, Umberto Veronesi · Biomedicine & Pharmacotherapy · 1996 · 299 citations

Medicine, Cancer Biology, Oncology +8

Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials

Lesley Stewart, Kristian Aabo, P I Adnitt et al. · 1991 · 271 citations

Medicine, Gynecology, Oncology +14